| References |
|
|
Ahima RS,
Prabakaran D,
Mantzoros C et al.
(1996)
Role of leptin in the neuroendocrine response to fasting.
Nature
382(6588):
250–252.
|
|
|
Asakawa A,
Inui A,
Kaga T et al.
(2001)
Ghrelin is an appetite‐stimulatory signal from stomach with structural resemblance to motilin.
Gastroenterology
120(2):
337–345.
|
|
|
Baranowska B,
Wolinska‐Witort E,
Martynska L,
Chmielowska M and
Baranowska‐Bik A
(2005)
Plasma orexin A, orexin B, leptin, neuropeptide Y (NPY) and insulin in obese women.
Neuroendocrinology Letters
26(4):
293–296.
|
|
|
Bittencourt JC,
Presse F,
Arias C et al.
(1992)
The melanin‐concentrating hormone system of the rat brain: an immuno‐ and hybridization histochemical characterization.
Journal of Comparative Neurology
319(2):
218–245.
|
|
|
Cai XJ,
Widdowson PS,
Harrold J et al.
(1999)
Hypothalamic orexin expression: modulation by blood glucose and feeding.
Diabetes
48(11):
2132–2137.
|
|
|
Caylak E
(2009)
The genetics of sleep disorders in humans: narcolepsy, restless legs syndrome, and obstructive sleep apnea syndrome.
American Journal of Medical Genetics
149A(11):
2612–2626.
|
|
|
Cerda‐Reverter JM and
Larhammar D
(2000)
Neuropeptide Y family of peptides: structure, anatomical expression, function, and molecular evolution.
International Journal of Biochemistry and Cell Biology
78(3):
371–392.
|
|
|
Coll AP,
Farooqi IS and
O'Rahilly S
(2007)
The hormonal control of food intake.
Cell
129(2):
251–262.
|
|
|
Cowley MA,
Smith RG,
Diano S et al.
(2003)
The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis.
Neuron
37(4):
649–661.
|
|
|
Cummings DE and
Overduin J
(2007)
Gastrointestinal regulation of food intake.
Journal of Clinical Investigation
117(1):
13–23.
|
|
|
Della‐Zuana O,
Presse F,
Ortola C et al.
(2002)
Acute and chronic administration of melanin‐concentrating hormone enhances food intake and body weight in Wistar and Sprague–Dawley rats.
International Journal of Obesity and Related Metabolic Disorders
26(10):
1289–1295.
|
|
|
Dickson SL and
Luckman SM
(1997)
Induction of c‐fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)‐releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH‐releasing peptide‐6.
Endocrinology
138(2):
771–777.
|
|
|
Fan W,
Boston BA,
Kesterson RA,
Hruby VJ and
Cone RD
(1997)
Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.
Nature
385(6612):
165–168.
|
|
|
Fetissov S,
Kopp J and
Hokfelt T
(2004)
Distribution of NPY receptors in the hypothalamus.
Neuropeptides
38(4):
175–188.
|
|
|
Fisher SL,
Yagaloff KA and
Burn P
(1999)
Melanocortin‐4 receptor: a novel signalling pathway involved in body weight regulation.
International Journal of Obesity and Related Metabolic Disorders
23(suppl. 1):
54–58.
|
|
|
Fruhbeck G
(2006)
Intracellular signalling pathways activated by leptin.
Biochemical Journal
393(Pt 1):
7–20.
|
|
|
Guan XM,
Yu H,
Palyha OC et al.
(1997)
Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues.
Brain Research Molecular Brain Research
48(1):
23–29.
|
|
|
Hagan MM,
Rushing PA,
Pritchard LM et al.
(2000)
Long‐term orexigenic effects of AgRP(83–132) involve mechanisms other than melanocortin receptor blockade.
American Journal of Physiology
279(1):
R47–R52.
|
|
|
Halford JCG and
Blundell JE
(2000)
Separate systems for serotonin and leptin in appetite control.
Annals of Medicine
32(3):
222–232.
|
|
|
Harrold JA
(2004)
Hypothalamic control of energy balance.
Current Drug Targets
5(3):
207–219.
|
|
|
Hinney A,
Schmidt A,
Nottebom K et al.
(1999)
Several mutations in the melanocortin‐4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans.
Journal of Clinical Endocrinology and Metabology
84(4):
1483–1486.
|
|
|
Huang XF,
Han M and
Storlien LH
(2003)
The level of NPY receptor mRNA expression in diet‐induced obese and resistant mice.
Brain Research Molecular Brain Research
115(1):
21–28.
|
|
|
Huxley R,
James WP,
Barzi F et al.
(2008)
Ethnic comparisons of the cross‐sectional relationships between measures of body size with diabetes and hypertension.
Obesity Reviews
9(suppl. 1):
53–61.
|
|
|
Kalra SP,
Dube MG,
Sahu A,
Phelps CP and
Kalra PS
(1991)
Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food.
Proceedings of the National Academy of Sciences of the USA
88(23):
10931–10935.
|
|
|
Kirkham TC
(2005)
Endocannabinoids in the regulation of appetite and body weight.
Behavioural Pharmacology
16(5–6):
297–313.
|
|
|
Kohno D,
Nakata M,
Maekawa F et al.
(2007)
Leptin suppresses ghrelin‐induced activation of neuropeptide Y neurons in the arcuate nucleus via phosphatidylinositol 3‐kinaseand phosphodiesterase‐3‐mediated pathway.
Endocrinology
148(5):
2251–2263.
|
|
|
Kojima M,
Hosoda H,
Date Y et al.
(1999)
Ghrelin is a growth‐hormone‐releasing acylated peptide from stomach.
Nature
402(6762):
656–660.
|
|
|
Kola B,
Farkas I,
Christ‐Crain M et al.
(2008)
The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system.
PLoS One
3(3):
e1797.
|
|
|
Kotz CM,
Briggs JE,
Grace MK,
Levine AS and
Billington CJ
(1998)
Divergence of the feeding and thermogenic pathways influenced by NPY in the hypothalamic PVN of the rat.
American Journal of Physiology
275(2 Pt 2):
R471–R477.
|
|
|
Kumano S,
Matsumoto H,
Takatsu Y et al.
(2003)
Changes in hypothalamic expression levels of galanin‐like peptide in rat and mouse models support that it is a leptin‐target peptide.
Endocrinology
144(6):
2634–2643.
|
|
|
Kyrkouli SE,
Stanley BG,
Seirafi RD and
Leibowitz SF
(1990)
Stimulation of feding by galanin: anatomical localization and behavioral specificity of this peptide's effects in the brain.
Peptides
11(5):
995–1001.
|
|
|
Leibowitz SF
(2005)
Regulation and effects of hypothalamic galanin: relation to dietary fat, alcohol ingestion, circulating lipids and energy homeostasis.
Neuropeptides
39(3):
327–332.
|
|
|
Lin EJ,
Sainsbury A,
Lee NJ et al.
(2006)
Combined deletion of Y1, Y2 and Y4 receptors prevents hypothalamic NPY overexpression‐induced hyperinsulinemia despite persistence of hyperphagia and obesity.
Endocrinology
147(11):
5094–5101.
|
|
|
Lopez M,
Seoane L,
Garcia MC et al.
(2000)
Leptin regulation of prepro‐orexin and orexin receptor mRNA levels in the hypothalamus.
Biochemical and Biophysical Research Communications
269(1):
41–45.
|
|
|
Lopez M,
Seoane LM,
Garcia Mdel C et al.
(2002)
Neuropeptide Y, but not agouti‐related peptide or melanin‐concentrating hormone, is a target peptide for orexin‐A feeding actions in the rat hypothalamus.
Neuroendocrinology
75(1):
34–44.
|
|
|
Ludwig DS,
Tritos NA,
Mastaitis JW et al.
(2001)
Melanin‐concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance.
Journal of Clinical Investigation
107(3):
379–386.
|
|
|
Man PS and
Lawrence CB
(2008)
The effects of galanin‐like peptide on energy balance, body temperature and brain activity in the mouse and rat are independent of the GALR2/3 receptor.
Journal of Neuroendocrinology
20(1):
128–137.
|
|
|
Marks JL,
Porte D Jr,
Stahl WL and
Baskin DG
(1990)
Localization of insulin receptor mRNA in rat brain by in situ hybridization.
Endocrinology
127(6):
3234–3236.
|
|
|
Marsh DJ,
Weingarth DT,
Novi DE et al.
(2002)
Melanin‐concentrating hormone 1 receptor deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism.
Proceedings of the National Academy of Sciences of the USA
99(5):
3240–3245.
|
|
|
Masuda Y,
Tanaka T,
Inomata N et al.
(2000)
Ghrelin stimulates gastric acid secretion and motility in rats.
Biochemical and Biophysical Research Communications
276(3):
905–908.
|
|
|
Mizuno TM and
Mobbs CV
(1999)
Hypothalamic agouti‐related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting.
Endocrinology
140(2):
814–817.
|
|
|
Nakazato M,
Murakami N,
Date Y et al.
(2001)
A role for ghrelin in the central regulation of feeding.
Nature
409(6817):
194–198.
|
|
|
Pagotto U,
Marsicano G,
Cota D,
Lutz B and
Pasquali R
(2006)
The emerging role of the endocannabinoid system in endocrine regulation and energy balance.
Endocrine Reviews
27(1):
73–100.
|
|
|
Pelleymounter MA,
Cullen MJ,
Baker MB et al.
(1995)
Effects of the obese gene product on body weight regulation in ob/ob mice.
Science
269(5223):
540–543.
|
|
|
Pliquett RU,
Fuhrer D,
Falk S et al.
(2006)
The effects of insulin on the central nervous system–focus on appetite regulation.
Hormone and Metabolic Research
38(7):
442–446.
|
|
|
Sahu A
(1998)
Leptin decreases food intake induced by melaninconcentrating hormone (MCH), galanin (GAL) and neuropeptide Y (NPY) in the rat.
Endocrinology
139(11):
4739–4742.
|
|
|
Sakurai T,
Amemiya A,
Ishii M et al.
(1998)
Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein‐coupled receptors that regulate feeding behaviour.
Cell
92(4):
573–585.
|
|
|
Schauble N,
Reichwald K,
Grassl W et al.
(2005)
Human galanin (GAL) and galanin 1 receptor (GALR1) variations are not involved in fat intake and early onset obesity.
Journal of Nutrition
135(6):
1387–1392.
|
|
|
Takenoya F,
Hirayama M,
Kageyama H et al.
(2005)
Neuronal interactions between galanin‐like peptide‐ and orexin‐ or melanin‐concentrating hormone‐containing neurons.
Regulatory Peptides
126(1–2):
79–83.
|
|
|
Tritos NA and
Muratos‐Flier E
(1999)
Two important systems in energy homeostasis: melanocortins and melanin‐concentrating hormone.
Neuropeptides
33(5):
339–349.
|
|
|
Tschop M,
Smiley DL and
Heiman ML
(2000)
Ghrelin induces adiposity in rodents.
Nature
407(6806):
908–913.
|
|
|
Van Der Kolk N,
Madison FN,
Mohr M et al.
(2010)
Alarin stimulates food intake in male rats and LH secretion in castrated male rats.
Neuropeptides
44(4):
333–340.
|
|
|
book
WHO
(2004)
"Overweight and obesity (high body mass index)".
Chapter 8.
In: James WPT et al. (ed.)
Comparative quantification of health risks global and regional burden of diseases attributable to selected major risk factors.
Geneva: WHO.
|
|
|
other
WHO/NUT/NCD
(2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation in obesity. WHO TRS 894: Geneva.
|
|
|
Yamanaka A,
Sakurai T,
Katsumoto T,
Yanagisawa M and
Goto K
(1999)
Chronic intracerebroventricular administration of orexin‐A to rats increases food intake in daytime, but has no effect on body weight.
Brain Research
849(1–2):
248–252.
|
| Further Reading |
|
|
Aydin S
(2007)
Discovery of ghrelin hormone: research and clinical applications.
Turkish Journal of Biochemistry
32(2):
76–89.
|
|
|
Aydin S,
Halifeoglu I,
Ozercan IH et al.
(2005)
A comparison of leptin and ghrelin levels in plasma and saliva of young healthy subjects.
Peptides
26(4):
647–625.
|
|
|
Aydin S,
Ozkan Y,
Caylak E and
Aydin S
(2006)
Ghrelin and its biochemical functions: review.
Journal of Medical Sciences
26(3):
272–283.
|
|
|
Valassi E,
Scacchi M and
Cavagnini F
(2008)
Neuroendocrine control of food intake.
Nutrition, Metabolism and Cardiovascular Diseases
18(2):
158–168.
|
|
|
book
Williams G and
Frühbeck Gema (eds)
(2009)
Obesity: Science to Practice.
Oxford: John Wiley & Sons, Ltd.
|
| Web Links |
|
|
ePath
IASO/IOTF
(2010) Obesity the global epidemic. http://www.iaso.org/iotf/obesity/obesitytheglobalepidemic/
|
|
|
ePath
WHO
(2006) Factsheet 311 September. http://www.who.int/mediacentre/factsheets/fs311/en/index.html
|
|
|
ePath
WHO
(2007) WHO statement: Controlling the global obesity epidemic. http://www.who.int/nutrition/topics/obesity/en/
|
